STEPHEN ROCAMBOLI - 10 May 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
10 May 2023
Net transactions value
+$12,126
Form type
4
Filing time
11 May 2023, 16:10:27 UTC
Previous filing
13 Mar 2023
Next filing
16 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Purchase $12,126 +8,111 $1.50 8,111 10 May 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.